James Carter
Affiliations: | 2008-2012 | University of Bristol, Bristol, England, United Kingdom |
Google:
"James Carter"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Stone OA, Carter JG, Lin PC, et al. (2016) Differential regulation of blood flow induced neovascularisation and mural cell recruitment by VEGF and angiopoietin signalling. The Journal of Physiology |
| Bunni J, Shelley-Fraser G, Stevenson K, et al. (2015) Circulating levels of anti-angiogenic VEGF-A isoform (VEGF-Axxxb) in colorectal cancer patients predicts tumour VEGF-A ratios. American Journal of Cancer Research. 5: 2083-9 |
| Carter JG, Gammons MV, Damodaran G, et al. (2015) The carboxyl terminus of VEGF-A is a potential target for anti-angiogenic therapy. Angiogenesis. 18: 23-30 |
| Bates DO, Mavrou A, Qiu Y, et al. (2013) Detection of VEGF-A(xxx)b isoforms in human tissues. Plos One. 8: e68399 |
| Carter JG, Cherry J, Williams K, et al. (2011) Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease. Current Eye Research. 36: 328-35 |
| Churchill AJ, Carter JG, Ramsden C, et al. (2008) VEGF polymorphisms are associated with severity of diabetic retinopathy. Investigative Ophthalmology & Visual Science. 49: 3611-6 |
| Churchill AJ, Carter JG, Lovell HC, et al. (2006) VEGF polymorphisms are associated with neovascular age-related macular degeneration. Human Molecular Genetics. 15: 2955-61 |